search
Back to results

Cognitive Level Enhancement Through Vision Exams and Refraction (CLEVER)

Primary Purpose

Refractive Errors

Status
Not yet recruiting
Phase
Not Applicable
Locations
India
Study Type
Interventional
Intervention
Free near and Distance Vision glasses
Sponsored by
Queen's University, Belfast
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Refractive Errors focused on measuring Cognitive Decline, Elderly, Refractive Error, Spectacles

Eligibility Criteria

60 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria

  1. Community dwelling
  2. Residency

    a. Participants must plan to reside in the local area for the study duration

  3. Presenting vision in the better eye due to uncorrected refractive error

    1. Impaired distance vision less than 6/12
    2. Near vision less than N8 at 40 cm
  4. Presenting vision in the better eye due to under-corrected refractive error

    1. Impaired distance vision less than 6/12
    2. Near vision less than N8 at 40 cm
  5. Willingness

    1. to participate
    2. to be randomized
    3. to adhere to the protocol

Exclusion criteria

  1. Impaired baseline cognition

    a. HMSE score less than or equal to 18

  2. Non-refractive causes of vision impairment
  3. Severely impaired mobility

    1. immobile
    2. bedridden
    3. wheelchair
    4. using walker
  4. Severe medical illness likely to limit the life span

    1. Cancer
    2. Heart disease
    3. Stroke
    4. HIV or AIDS
    5. Chronic lung disease
    6. Kidney disease
  5. Hearing loss assessment

    1. self-reported hearing impairment
    2. inability to hear
    3. inability to repeat short phrases in local languages

Sites / Locations

  • L V Prasad Eye Institute

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Free near and distance glasses

Control-No treatment

Arm Description

All participants randomised to the intervention group will be provided with free near and/or distance spectacles based on the results of refraction. The participants will be asked to choose from an assortment of 20 frames. Participants will be asked to report to the project coordinator in case of any issue with spectacles or if spectacles are lost or broken. Replacement glasses will be provided in case of broken or lost spectacles whenever required. Participants will undergo annual eye exams and refraction, and change of glasses will be prescribed as needed.

All participants randomised to the control group will receive a prescription for spectacles and given free near and/or distance glasses as needed at study close out.

Outcomes

Primary Outcome Measures

Change in cognitive score
The metric or method of measurement to be used: LASI-DAD global cognitive score. The best possible score is 360 and the worst possible score is 0.

Secondary Outcome Measures

26-Item Quality of Life
The metric or method of measurement to be used: Quality of Life using WHO BREF questionnaire. Higher scores (for 4 domains) indicate higher quality of life and vice versa (it is a continuum)
Cost effectiveness
The metric or method of measurement to be used: Cost-effectiveness using Client Service Receipt Inventory
Social interaction/isolation
The metric or method of measurement to be used: Social Networking Index. The best possible score is 12 and the worst possible score is 0
Self-reported physical activity.
The metric or method of measurement to be used: Global Physical Activity Questionnaire Self-reported physical activity: Global Physical Activity Questionnaire (GPAQ).
Falls
The metric or method of measurement to be used: Quick Screen for falls Risk. The worst possible score is 7% and the best possible score is 49%
Depression
The metric or method of measurement to be used: Patient Health Questionnaire, PHQ9. Worst score is 0 and best possible score is 27
Glasses compliance
The metric or method of measurement to be used: Use of glasses during follow-up visits. The best possible score is 1 and the worst possible score is 0
Visual Function
The metric or method of measurement to be used: Indian VFQ. The measure will be in logits (using Rasch-scaled interval scores) and it is a continuum with positive person scores indicating lower visual functioning and negative scores indicating better visual functioning.
Domain-specific cognitive function
The metric or method of measurement to be used: Hindi Mental State Examination. The best possible score is 31 and the worst possible score is 0.

Full Information

First Posted
July 11, 2022
Last Updated
August 2, 2023
Sponsor
Queen's University, Belfast
Collaborators
L.V. Prasad Eye Institute, National Institute of Mental Health and Neuro Sciences, India, The George Institute, Johns Hopkins University, University of Michigan, Clearly, Belfast Health and Social Care Trust
search

1. Study Identification

Unique Protocol Identification Number
NCT05458323
Brief Title
Cognitive Level Enhancement Through Vision Exams and Refraction
Acronym
CLEVER
Official Title
Cognitive Level Enhancement Through Vision Exams and Refraction: a Randomized Controlled Trial to Assess Impact of Near and Distance Spectacles on Reducing Rates of Cognitive Decline With Aging in Community Dwelling Older People in India
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
September 2023 (Anticipated)
Primary Completion Date
August 2025 (Anticipated)
Study Completion Date
September 2026 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Queen's University, Belfast
Collaborators
L.V. Prasad Eye Institute, National Institute of Mental Health and Neuro Sciences, India, The George Institute, Johns Hopkins University, University of Michigan, Clearly, Belfast Health and Social Care Trust

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The investigators aim to conduct a mixed-method study in which a randomised controlled trial (RCT) and a descriptive qualitative study will be conducted. The RCT aims to determine whether free near and distance glasses provided to residents in Hyderabad, India, aged ≥ 60 years, with under- or un- corrected refractive error and normal baseline hearing and cognition (HMSE > 18), can improve quality of life, reduce falls, reduce depression, improve social interaction and physical activity cost-effectively over 36 months. The primary qualitative research aim is to a) contextualize the RCT with information on the milieu and culture in which the trial will be conducted; b) provide data on the lived experiences of older adults with reduced vision in the study area, and c) conduct a process evaluation of the trial. The primary outcome measure is the three-year change in cognition measured by LASI- DAD (Longitudinal Aging Study in India(LASI)- Diagnostic Assessment of Dementia(DAD) global cognitive score. Secondary Outcome Measures: Domain-specific cognitive function (orientation, executive function, language/fluency, memory), quality of life (WHOQOL BREF), self-reported visual functioning (INDVFQ), falls, mobility, depression (PHQ9), glasses compliance, cost-effectiveness (total intervention cost per additional quality-adjusted life years(QALY) gained in the intervention group), social interaction/isolation (Social Networking Index, SNI), self-reported physical activity (GPAQ). An additional secondary outcome will be LASI-DAD global cognitive score analysed by excluding any tests determined pre-hoc to depend on visual acuity.
Detailed Description
The number of people living with dementia globally will rise from 50 million in 2017 to 131.5 million by 2050. The majority reside in low and middle-income countries (LMICs), where a 223% increase in the burden of dementia is expected from 2015 to 2050. The household cost of caring for demented relatives in India was £2.48 billion in 2013, where total expenses for dementia care will soon consume 0.5% of Gross Domestic Product (GDP). Despite the rapidly-growing burden of dementia in India, only 1 in 10 affected are diagnosed or treated. Proven preventive strategies are desperately needed to close the gap, and could reduce incidence by an estimated 41%, especially early, at the stage of mild cognitive impairment, which itself increases risk of dementia by 23-fold. Existing interventions have predominantly been evaluated in high-income countries (HIC), despite the acknowledged need for prevention in low resource settings. India's national dementia strategy, documented in the Alzheimer's and Related Society of India (ARDSI) Report (2018) and Dementia in India (2020), echo the WHO Dementia Global Action Plan (2017) in prioritising evidence-based approaches to reduce risk. The elderly, at greatest risk for cognitive disorders, also have the highest prevalence of vision impairment, which affects 2.2 billion persons globally. Growing longitudinal evidence links vision impairment and risk of cognitive decline, with population studies in the United States reporting a 55% increased 9-year risk of new cognitive impairment among visually impaired persons. Longitudinal studies elsewhere in the United States, France, Singapore and China report similar results. While vision impairment is a strong predictor of future cognitive performance, cognition is relatively weakly linked to future visual decline. Both distance impairment and impairment of near vision, a nearly universal part of aging without refractive correction, have been implicated. Observational studies also suggest vision care slows rates of cognitive decline by up to 50%. The association between vision loss and cognitive decline and dementia, while consistent and strong, is not well understood, and various causal pathways have been posited. These include common neurodegenerative or micro vascular aetiology, increased cognitive load, and limited social contact and physical activity due to poor vision, each independently shown to elevate risk of dementia. Studies investigating the role of vision correction in slowing cognitive decline will have a significant impact in developing strategies to reduce the burden of dementia. Design: single centre, open label, two-arm, parallel group, stratified, interventional randomised trial with a qualitative component Rationale: Despite considerable longitudinal observational evidence, there have been no randomised trials to investigate whether providing near and distance glasses can slow cognitive decline in the elderly. Proof of a causative association between vision correction and the slowing of cognitive decline is needed to potentiate investment in inexpensive vision care for prevention. This requires randomised trials, and none have yet been done. Study Plan: Eligibility assessments conducted for 1300 participants. After providing the consent and meeting the eligibility criteria, 760 participants randomised to intervention and control groups. Annual follow-ups for 3 years for both groups. Lost to follow ups documented with reason for both groups. Missed data for both groups analysed as intention to treat (ITT) and will be excluded from analysis with reasons documented. Primary outcomes: Three-year change in cognition measured by LASI-DAD global cognitive score. Secondary Outcome Measures: Domain-specific cognitive function (orientation, executive function, language/fluency, memory), quality of life (WHOQOL BREF), self-reported visual functioning (INDVFQ), falls, mobility, depression (PHQ9), glasses compliance, cost-effectiveness (total intervention cost per additional QALY gained in the intervention group), social interaction/isolation (Social Networking Index, SNI), self-reported physical activity (GPAQ). An additional secondary outcome will be LASI-DAD global cognitive score analysed by excluding any tests determined pre-hoc to depend on visual acuity. Hindi Mental State Examination, Medical history and comorbidity questionnaire, Hearing Questionnaire, Client Services Receipt Inventory. Statistical methods: The primary analysis will use a significance level of <0.05 and will compare the change in LASI-DAD global cognitive score (primary outcome, with sensitivity analysis including and excluding vision-dependent tests) between groups using a 2-sample t-test. Both the raw comparison, and the comparison adjusting for potential determinants of change in cognitive status, such as baseline cognitive score, age, sex and education (further covariates will be detailed in the SAP) using general linear models. Similar methods will be used for other time-points and secondary outcomes that are continuous data. Justification for sample size: Imputing three-year un-intervened decline in the outcome variable (LASI-DAD global score from cross-sectional, age-stratified data17, at 29% effect size (from the ACHIEVE study), 502 participants give 90% power at p = 0.05 (two-tailed) based on a two-sample test. With annual follow-up loss of 13% based on estimation from previous studies done in India, 760 total participants are needed across the two study groups. With 60% prevalence of uncorrected distance and/or near refractive error, the total number of people needing to be screened is estimated at approximately 1300.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Refractive Errors
Keywords
Cognitive Decline, Elderly, Refractive Error, Spectacles

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
CLEVER is a single centre, open label, 2-arm, parallel group, stratified, interventional randomised trial, with allocation ratio of 1:1 powered to test superiority of the impact of providing spectacles on rates of cognitive decline among older adults.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
760 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Free near and distance glasses
Arm Type
Experimental
Arm Description
All participants randomised to the intervention group will be provided with free near and/or distance spectacles based on the results of refraction. The participants will be asked to choose from an assortment of 20 frames. Participants will be asked to report to the project coordinator in case of any issue with spectacles or if spectacles are lost or broken. Replacement glasses will be provided in case of broken or lost spectacles whenever required. Participants will undergo annual eye exams and refraction, and change of glasses will be prescribed as needed.
Arm Title
Control-No treatment
Arm Type
No Intervention
Arm Description
All participants randomised to the control group will receive a prescription for spectacles and given free near and/or distance glasses as needed at study close out.
Intervention Type
Device
Intervention Name(s)
Free near and Distance Vision glasses
Intervention Description
Intervention Description: All participants randomised to the intervention group will be provided with free near and/or distance spectacles based on the results of refraction.
Primary Outcome Measure Information:
Title
Change in cognitive score
Description
The metric or method of measurement to be used: LASI-DAD global cognitive score. The best possible score is 360 and the worst possible score is 0.
Time Frame
Time point(s) of primary interest: 36 months collected at 12, 24 and 36 months
Secondary Outcome Measure Information:
Title
26-Item Quality of Life
Description
The metric or method of measurement to be used: Quality of Life using WHO BREF questionnaire. Higher scores (for 4 domains) indicate higher quality of life and vice versa (it is a continuum)
Time Frame
Time point(s) of primary interest: 36 months collected every 12 months - ie at 12, 24 and 36 months
Title
Cost effectiveness
Description
The metric or method of measurement to be used: Cost-effectiveness using Client Service Receipt Inventory
Time Frame
Time point(s) of primary interest: 36 months collected every 12 months - ie at 12, 24 and 36 months
Title
Social interaction/isolation
Description
The metric or method of measurement to be used: Social Networking Index. The best possible score is 12 and the worst possible score is 0
Time Frame
Time point(s) of primary interest: 36 months collected every 12 months - ie at 12, 24 and 36 months
Title
Self-reported physical activity.
Description
The metric or method of measurement to be used: Global Physical Activity Questionnaire Self-reported physical activity: Global Physical Activity Questionnaire (GPAQ).
Time Frame
Time point(s) of primary interest: 36 months collected every 12 months - ie at 12, 24 and 36 months
Title
Falls
Description
The metric or method of measurement to be used: Quick Screen for falls Risk. The worst possible score is 7% and the best possible score is 49%
Time Frame
Time point(s) of primary interest: 36 months collected every 12 months - ie at 12, 24 and 36 months
Title
Depression
Description
The metric or method of measurement to be used: Patient Health Questionnaire, PHQ9. Worst score is 0 and best possible score is 27
Time Frame
Time point(s) of primary interest: 36 months collected every 12 months - ie at 12, 24 and 36 months
Title
Glasses compliance
Description
The metric or method of measurement to be used: Use of glasses during follow-up visits. The best possible score is 1 and the worst possible score is 0
Time Frame
Time point(s) of primary interest: 36 months collected every 12 months - ie at 12, 24 and 36 months
Title
Visual Function
Description
The metric or method of measurement to be used: Indian VFQ. The measure will be in logits (using Rasch-scaled interval scores) and it is a continuum with positive person scores indicating lower visual functioning and negative scores indicating better visual functioning.
Time Frame
Time point(s) of primary interest: 36 months collected every 12 months - ie at 12, 24 and 36 months
Title
Domain-specific cognitive function
Description
The metric or method of measurement to be used: Hindi Mental State Examination. The best possible score is 31 and the worst possible score is 0.
Time Frame
Time point(s) of primary interest: 36 months collected every 12 months - ie at 12, 24 and 36 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria Community dwelling Residency a. Participants must plan to reside in the local area for the study duration Presenting vision in the better eye due to uncorrected refractive error Impaired distance vision less than 6/12 Near vision less than N8 at 40 cm Presenting vision in the better eye due to under-corrected refractive error Impaired distance vision less than 6/12 Near vision less than N8 at 40 cm Willingness to participate to be randomized to adhere to the protocol Exclusion criteria Impaired baseline cognition a. HMSE score less than or equal to 18 Non-refractive causes of vision impairment Severely impaired mobility immobile bedridden wheelchair using walker Severe medical illness likely to limit the life span Cancer Heart disease Stroke HIV or AIDS Chronic lung disease Kidney disease Hearing loss assessment self-reported hearing impairment inability to hear inability to repeat short phrases in local languages
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Nathan G Congdon, MD, MPH
Phone
+44(0)289097
Ext
8929
Email
n.congdon@qub.ac.uk
First Name & Middle Initial & Last Name or Official Title & Degree
Rohit C Khanna, MPH
Phone
914035225600
Email
rohit@lvpei.org
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nathan G Congdon, MD, MPH
Organizational Affiliation
Queen's University, Belfast
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Rohit C Khanna, MPH
Organizational Affiliation
L.V. Prasad Eye Institute
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Suvarna Alladi, DM
Organizational Affiliation
National Institute of Mental Health and Neuro Sciences, India
Official's Role
Principal Investigator
Facility Information:
Facility Name
L V Prasad Eye Institute
City
Hyderabad
State/Province
Telangana
ZIP/Postal Code
500086
Country
India
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Rohit C Khanna, MPH
Phone
914035225600
Email
rohit@lvpei.org
First Name & Middle Initial & Last Name & Degree
Srinivas Marmamula, PhD
Phone
914035225613
Email
sri.marmamula@lvpei.org

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
All Individual Participant Data(IPD) will be stored in anonymised format. The IPD that includes personal identifiable information will be deleted when the data collection process is complete and before the initiation of data analysis. Only de-identified data will be shared with all the researchers for analysis. The primary analysis will be conducted on all outcome data obtained from all enrolled participants as randomised.
IPD Sharing Time Frame
All deidentified IPD will be available from September 2022 (anticipated Trial start date) to September 2035 (inclusive of analysis, publication and archival).
IPD Sharing Access Criteria
Following publication of the primary and secondary outcomes there may be scope to conduct additional analyses on the data collected. In such instances formal requests for data will need to be made in writing to the Chief Investigator, who will discuss this with the Sponsor. The study will comply with the good practice principles for sharing individual participant data from publicly funded clinical trials and data sharing will be undertaken in accordance with the required regulatory requirements
Citations:
PubMed Identifier
31221887
Citation
Salcher-Konrad M, Naci H, McDaid D, Alladi S, Oliveira D, Fry A, Hussein S, Knapp M, Musyimi CW, Ndetei DM, Lopez-Ortega M, Comas-Herrera A. Effectiveness of interventions for dementia in low- and middle-income countries: protocol for a systematic review, pairwise and network meta-analysis. BMJ Open. 2019 Jun 19;9(6):e027851. doi: 10.1136/bmjopen-2018-027851.
Results Reference
background
PubMed Identifier
31000118
Citation
Walker R, Paddick SM. Dementia prevention in low-income and middle-income countries: a cautious step forward. Lancet Glob Health. 2019 May;7(5):e538-e539. doi: 10.1016/S2214-109X(19)30169-X. No abstract available.
Results Reference
background
PubMed Identifier
30358809
Citation
Swenor BK, Wang J, Varadaraj V, Rosano C, Yaffe K, Albert M, Simonsick EM. Vision Impairment and Cognitive Outcomes in Older Adults: The Health ABC Study. J Gerontol A Biol Sci Med Sci. 2019 Aug 16;74(9):1454-1460. doi: 10.1093/gerona/gly244. Erratum In: J Gerontol A Biol Sci Med Sci. 2019 Jan 14;:
Results Reference
background
PubMed Identifier
30610413
Citation
Nael V, Peres K, Dartigues JF, Letenneur L, Amieva H, Arleo A, Scherlen AC, Tzourio C, Berr C, Carriere I, Delcourt C, Helmer C; Sense-Cog consortium. Vision loss and 12-year risk of dementia in older adults: the 3C cohort study. Eur J Epidemiol. 2019 Feb;34(2):141-152. doi: 10.1007/s10654-018-00478-y. Epub 2019 Jan 4.
Results Reference
background
PubMed Identifier
32297918
Citation
Tran EM, Stefanick ML, Henderson VW, Rapp SR, Chen JC, Armstrong NM, Espeland MA, Gower EW, Shadyab AH, Li W, Stone KL, Pershing S. Association of Visual Impairment With Risk of Incident Dementia in a Women's Health Initiative Population. JAMA Ophthalmol. 2020 Jun 1;138(6):624-633. doi: 10.1001/jamaophthalmol.2020.0959.
Results Reference
background
PubMed Identifier
32324240
Citation
Lim ZW, Chee ML, Soh ZD, Cheung N, Dai W, Sahil T, Tao Y, Majithia S, Sabanayagam C, Chen CL, Wong TY, Cheng CY, Tham YC. Association Between Visual Impairment and Decline in Cognitive Function in a Multiethnic Asian Population. JAMA Netw Open. 2020 Apr 1;3(4):e203560. doi: 10.1001/jamanetworkopen.2020.3560. Erratum In: JAMA Netw Open. 2020 May 1;3(5):e209437.
Results Reference
background
PubMed Identifier
32043518
Citation
Lee ATC, Richards M, Chan WC, Chiu HFK, Lee RSY, Lam LCW. Higher Dementia Incidence in Older Adults with Poor Visual Acuity. J Gerontol A Biol Sci Med Sci. 2020 Oct 15;75(11):2162-2168. doi: 10.1093/gerona/glaa036.
Results Reference
background
PubMed Identifier
29955805
Citation
Zheng DD, Swenor BK, Christ SL, West SK, Lam BL, Lee DJ. Longitudinal Associations Between Visual Impairment and Cognitive Functioning: The Salisbury Eye Evaluation Study. JAMA Ophthalmol. 2018 Sep 1;136(9):989-995. doi: 10.1001/jamaophthalmol.2018.2493.
Results Reference
background
PubMed Identifier
30307960
Citation
Maharani A, Dawes P, Nazroo J, Tampubolon G, Pendleton N; SENSE-Cog WP1 group. Cataract surgery and age-related cognitive decline: A 13-year follow-up of the English Longitudinal Study of Ageing. PLoS One. 2018 Oct 11;13(10):e0204833. doi: 10.1371/journal.pone.0204833. eCollection 2018. Erratum In: PLoS One. 2018 Nov 20;13(11):e0208045.
Results Reference
background
PubMed Identifier
27422439
Citation
Tan ZS, Spartano NL, Beiser AS, DeCarli C, Auerbach SH, Vasan RS, Seshadri S. Physical Activity, Brain Volume, and Dementia Risk: The Framingham Study. J Gerontol A Biol Sci Med Sci. 2017 Jun 1;72(6):789-795. doi: 10.1093/gerona/glw130.
Results Reference
background
PubMed Identifier
28658937
Citation
Rafnsson SB, Orrell M, d'Orsi E, Hogervorst E, Steptoe A. Loneliness, Social Integration, and Incident Dementia Over 6 Years: Prospective Findings From the English Longitudinal Study of Ageing. J Gerontol B Psychol Sci Soc Sci. 2020 Jan 1;75(1):114-124. doi: 10.1093/geronb/gbx087.
Results Reference
background
PubMed Identifier
32746673
Citation
Marmamula S, Challa R, Khanna RC, Kunkunu E, Rao GN. Population-based Assessment of Vision Impairment in the Elderly Population in Telangana State in India - Policy Implications for Eye Health Programmes. Ophthalmic Epidemiol. 2021 Apr;28(2):144-151. doi: 10.1080/09286586.2020.1797122. Epub 2020 Aug 4.
Results Reference
background
PubMed Identifier
31828848
Citation
Marmamula S, Challa R, Yellapragada S, Mohd J, Khanna RC. Temporal trends in the prevalence of spectacle use and spectacle coverage in India. Clin Exp Optom. 2020 Sep;103(5):693-698. doi: 10.1111/cxo.13025. Epub 2019 Dec 11.
Results Reference
background
PubMed Identifier
33820793
Citation
Marmamula S, Keeffe J, Challa R, Mohd J, Khanna RC. Near-vision impairment and effective near-vision spectacle coverage in two districts in Telangana, India: a population-based cross-sectional study. BMJ Open. 2021 Apr 5;11(4):e047131. doi: 10.1136/bmjopen-2020-047131.
Results Reference
background
PubMed Identifier
27979835
Citation
Marmamula S, Khanna RC, Kunkunu E, Rao GN. Population-based assessment of prevalence and causes of visual impairment in the state of Telangana, India: a cross-sectional study using the Rapid Assessment of Visual Impairment (RAVI) methodology. BMJ Open. 2016 Dec 15;6(12):e012617. doi: 10.1136/bmjopen-2016-012617.
Results Reference
background
PubMed Identifier
28277623
Citation
Marmamula S, Khanna RC, Kunuku E, Rao GN. Near visual impairment and spectacle coverage in Telangana, India. Clin Exp Ophthalmol. 2017 Aug;45(6):568-574. doi: 10.1111/ceo.12943. Epub 2017 Apr 5.
Results Reference
background
PubMed Identifier
32815603
Citation
Angrisani M, Jain U, Lee J. Sex Differences in Cognitive Health Among Older Adults in India. J Am Geriatr Soc. 2020 Aug;68 Suppl 3(Suppl 3):S20-S28. doi: 10.1111/jgs.16732.
Results Reference
background
PubMed Identifier
31371300
Citation
Lee J, Banerjee J, Khobragade PY, Angrisani M, Dey AB. LASI-DAD study: a protocol for a prospective cohort study of late-life cognition and dementia in India. BMJ Open. 2019 Jul 31;9(7):e030300. doi: 10.1136/bmjopen-2019-030300.
Results Reference
background
PubMed Identifier
32815602
Citation
Lee J, Khobragade PY, Banerjee J, Chien S, Angrisani M, Perianayagam A, Bloom DE, Dey AB. Design and Methodology of the Longitudinal Aging Study in India-Diagnostic Assessment of Dementia (LASI-DAD). J Am Geriatr Soc. 2020 Aug;68 Suppl 3(Suppl 3):S5-S10. doi: 10.1111/jgs.16737.
Results Reference
background
PubMed Identifier
9626712
Citation
Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychol Med. 1998 May;28(3):551-8. doi: 10.1017/s0033291798006667.
Results Reference
background
PubMed Identifier
19698578
Citation
Saxena S, Orley J; WHOQOL Group. Quality of life assessment: The world health organization perspective. Eur Psychiatry. 1997;12 Suppl 3:263s-6s. doi: 10.1016/S0924-9338(97)89095-5.
Results Reference
background
PubMed Identifier
21479777
Citation
Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, Bonsel G, Badia X. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011 Dec;20(10):1727-36. doi: 10.1007/s11136-011-9903-x. Epub 2011 Apr 9.
Results Reference
background
PubMed Identifier
20522529
Citation
Tiedemann A, Lord SR, Sherrington C. The development and validation of a brief performance-based fall risk assessment tool for use in primary care. J Gerontol A Biol Sci Med Sci. 2010 Aug;65(8):896-903. doi: 10.1093/gerona/glq067. Epub 2010 Jun 3.
Results Reference
background
PubMed Identifier
15834097
Citation
Gupta SK, Viswanath K, Thulasiraj RD, Murthy GV, Lamping DL, Smith SC, Donoghue M, Fletcher AE. The development of the Indian vision function questionnaire: field testing and psychometric evaluation. Br J Ophthalmol. 2005 May;89(5):621-7. doi: 10.1136/bjo.2004.050732.
Results Reference
background
PubMed Identifier
22308172
Citation
Gothwal VK, Bagga DK, Sumalini R. Rasch analysis of the Indian vision function questionnaire. Br J Ophthalmol. 2012 May;96(5):619-23. doi: 10.1136/bjophthalmol-2011-300092. Epub 2012 Feb 2.
Results Reference
background
PubMed Identifier
11556941
Citation
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13. doi: 10.1046/j.1525-1497.2001.016009606.x.
Results Reference
background
PubMed Identifier
20101923
Citation
Bull FC, Maslin TS, Armstrong T. Global physical activity questionnaire (GPAQ): nine country reliability and validity study. J Phys Act Health. 2009 Nov;6(6):790-804. doi: 10.1123/jpah.6.6.790.
Results Reference
background
PubMed Identifier
27540286
Citation
Aung MN, Moolphate S, Aung TN, Katonyoo C, Khamchai S, Wannakrairot P. The social network index and its relation to later-life depression among the elderly aged >/=80 years in Northern Thailand. Clin Interv Aging. 2016 Aug 8;11:1067-74. doi: 10.2147/CIA.S108974. eCollection 2016.
Results Reference
background
PubMed Identifier
10918349
Citation
Tsolaki M, Iakovidou V, Navrozidou H, Aminta M, Pantazi T, Kazis A. Hindi Mental State Examination (HMSE) as a screening test for illiterate demented patients. Int J Geriatr Psychiatry. 2000 Jul;15(7):662-4. doi: 10.1002/1099-1166(200007)15:73.0.co;2-5. No abstract available.
Results Reference
background
PubMed Identifier
25568477
Citation
Gambhir IS, Khurana V, Kishore D, Sinha AK, Mohapatra SC. A clinico-epidemiological study of cognitive function status of community-dwelling elderly. Indian J Psychiatry. 2014 Oct;56(4):365-70. doi: 10.4103/0019-5545.146531.
Results Reference
background
PubMed Identifier
1202204
Citation
Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189-98. doi: 10.1016/0022-3956(75)90026-6. No abstract available.
Results Reference
background
PubMed Identifier
30658677
Citation
Hemming K, Taljaard M, Grimshaw J. Introducing the new CONSORT extension for stepped-wedge cluster randomised trials. Trials. 2019 Jan 18;20(1):68. doi: 10.1186/s13063-018-3116-3.
Results Reference
background
PubMed Identifier
10940958
Citation
Sandelowski M. Whatever happened to qualitative description? Res Nurs Health. 2000 Aug;23(4):334-40. doi: 10.1002/1098-240x(200008)23:43.0.co;2-g.
Results Reference
background
PubMed Identifier
30453902
Citation
Munn Z, Peters MDJ, Stern C, Tufanaru C, McArthur A, Aromataris E. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol. 2018 Nov 19;18(1):143. doi: 10.1186/s12874-018-0611-x.
Results Reference
background
PubMed Identifier
21076562
Citation
Ustun TB, Chatterji S, Kostanjsek N, Rehm J, Kennedy C, Epping-Jordan J, Saxena S, von Korff M, Pull C; WHO/NIH Joint Project. Developing the World Health Organization Disability Assessment Schedule 2.0. Bull World Health Organ. 2010 Nov 1;88(11):815-23. doi: 10.2471/BLT.09.067231. Epub 2010 May 20.
Results Reference
background
PubMed Identifier
30456117
Citation
Erlingsson C, Brysiewicz P. A hands-on guide to doing content analysis. Afr J Emerg Med. 2017 Sep;7(3):93-99. doi: 10.1016/j.afjem.2017.08.001. Epub 2017 Aug 21.
Results Reference
background
PubMed Identifier
28700028
Citation
Guerrero-Castaneda RF, Menezes TMO, Ojeda-Vargas MG. Characteristics of the phenomenological interview in nursing research. Rev Gaucha Enferm. 2017 Jul 6;38(2):e67458. doi: 10.1590/1983-1447.2017.02.67458. English, Spanish.
Results Reference
background
PubMed Identifier
30504450
Citation
Peat G, Rodriguez A, Smith J. Interpretive phenomenological analysis applied to healthcare research. Evid Based Nurs. 2019 Jan;22(1):7-9. doi: 10.1136/ebnurs-2018-103017. Epub 2018 Dec 1. No abstract available.
Results Reference
background
PubMed Identifier
17594495
Citation
Akl EA, Treweek S, Foy R, Francis J, Oxman AD; ReBEQI group. NorthStar, a support tool for the design and evaluation of quality improvement interventions in healthcare. Implement Sci. 2007 Jun 26;2:19. doi: 10.1186/1748-5908-2-19.
Results Reference
background
PubMed Identifier
23311722
Citation
Grant A, Treweek S, Dreischulte T, Foy R, Guthrie B. Process evaluations for cluster-randomised trials of complex interventions: a proposed framework for design and reporting. Trials. 2013 Jan 12;14:15. doi: 10.1186/1745-6215-14-15.
Results Reference
background
PubMed Identifier
25791983
Citation
Moore GF, Audrey S, Barker M, Bond L, Bonell C, Hardeman W, Moore L, O'Cathain A, Tinati T, Wight D, Baird J. Process evaluation of complex interventions: Medical Research Council guidance. BMJ. 2015 Mar 19;350:h1258. doi: 10.1136/bmj.h1258.
Results Reference
background
PubMed Identifier
18824488
Citation
Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M; Medical Research Council Guidance. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ. 2008 Sep 29;337:a1655. doi: 10.1136/bmj.a1655.
Results Reference
background
PubMed Identifier
29454350
Citation
Forero R, Nahidi S, De Costa J, Mohsin M, Fitzgerald G, Gibson N, McCarthy S, Aboagye-Sarfo P. Application of four-dimension criteria to assess rigour of qualitative research in emergency medicine. BMC Health Serv Res. 2018 Feb 17;18(1):120. doi: 10.1186/s12913-018-2915-2.
Results Reference
background
PubMed Identifier
26666909
Citation
Hadi MA, Jose Closs S. Ensuring rigour and trustworthiness of qualitative research in clinical pharmacy. Int J Clin Pharm. 2016 Jun;38(3):641-6. doi: 10.1007/s11096-015-0237-6. Epub 2015 Dec 14.
Results Reference
background
PubMed Identifier
17872937
Citation
Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007 Dec;19(6):349-57. doi: 10.1093/intqhc/mzm042. Epub 2007 Sep 14.
Results Reference
background
PubMed Identifier
18252077
Citation
Hankins M, Smith H. GPAQ. Br J Gen Pract. 2007 Dec;57(545):994. doi: 10.3399/096016407782604956. No abstract available.
Results Reference
background
Citation
Shenton A. Strategies for Ensuring Trustworthiness in Qualitative Research Projects. Education for Information 2004;22:63-75
Results Reference
background
Citation
Rogers EM. Diffusion of innovations. New York: Free Press; 2003
Results Reference
background
Citation
Pawson R, Tilley N. Realistic evaluation: Sage; 1997 June 23.
Results Reference
background
Citation
Westhorp G. Realist impact evaluation: an introduction. London: Overseas Development Institute. 2014 Sep 25:1-
Results Reference
background
Citation
Stephenson, Judith M., John Imrie, and C. Bonell. Effective sexual health interventions: issues in experimental evaluation. Oxford University Press, 2003
Results Reference
background
Citation
Arksey H, O'Malley L. Scoping studies: towards a methodological framework. International Journal of Social Research Methodology 2005;8:19-32
Results Reference
background
Citation
Aromataris E MZE. JBI Manual for Evidence Synthesis. JBI: Adelaide, Australia (2020). 2020
Results Reference
background

Learn more about this trial

Cognitive Level Enhancement Through Vision Exams and Refraction

We'll reach out to this number within 24 hrs